Time toxicity associated with treatment of metastatic or unresectable gastro-oesophageal cancers in the second-line setting
Patients on second-line treatment for mGEC spent 1 in 4 days in contact with healthcare, and 30-day mortality following systemic treatment was high. These findings may guide decisions and informed consent surrounding second-line treatment in mGECs.
Authors
- Annette Tognela (ORCID: https://orcid.org/0000-0003-0875-4352)
- Robert Yoon (ORCID: https://orcid.org/0000-0002-7609-6067)
- Udit Nindra (ORCID: https://orcid.org/0000-0002-2612-9502)
- Rebecca Nguyen (ORCID: https://orcid.org/0000-0001-8940-3161)
- Wei Chua
- J. Tang
- Weng Ng
- Ray Asghari
- Stephanie Hui-Su Lim
Institutions
- Camden and Campbelltown Hospitals (AU)
- New South Wales Department of Health (AU)
- Bankstown Lidcombe Hospital (AU)
- Liverpool Hospital (AU)
- Ingham Institute (AU)
- Western Sydney University (AU)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1007/s00520-026-10359-w
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00